IL33 and neoplasm: We found exogenously administered recombinant mouse interleukin 33 promoted tumorsize and induced tumor-infiltrating ST2L+ regulatory T cells in tumor-bearingmice while neutralizing interleukin-33 or ST2L inhibited tumor size and decreasedST2L+ regulatory T cells.